focus -WSS

focus

author：comprehensive 2025-09-28 21:58:35 - browse：5

Matts Take Column Illustration — Molly Ferguson for STAT

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 medicines.

That could have a big, positive impact on public health, and it will very likely swell the coffers of the pharmaceutical companies that make these medicines, including Wegovy’s maker, Novo Nordisk, and Eli Lilly, now the most valuable drug company in history thanks largely to hopes for its GLP-1, Mounjaro. These are medicines that could save lives, make money, and perhaps reshape our culture. But they are also, we are learning, not without risk.

So what’s next?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Medical mystery: When a cough is not just a cough

explore

WSS

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

'Revelatory' study finds a smoking impact that remains after quitting

How AI helped researchers track recovery from depression

Medical mystery: When a cough is not just a cough

Changes to biosimilar regulatory framework must prioritize patients

Senators: Long

knowledge

focus

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Senators start work on Medicare physician payment reform

New air purifier tech could be key to improving indoor air quality

Ukraine and a new approach to mental health in war

Supreme Court strikes down use of affirmative action

Emergency workers more likely to restrain Black patients: study

What does generative AI mean for health care? We asked experts

Experts study whether long Covid risk adds up with each reinfection

Walensky prepares to leave CDC — and Congress — behind

Why are Kaiser Permanente staff considering a strike?

knowledge

Robert F. Kennedy is pitching centrism on health, even on abortion

Why are Kaiser Permanente staff considering a strike?

FDA panel to weigh approval of NurOwn, controversial ALS drug

Senators start work on Medicare physician payment reform

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Hearing on Medicare drug price negotiation gets unusually heated

Wikipedia

explore

focus

focus